Skip to main content

Penile Cancer

Penile cancer, though rare, is a serious disease that requires awareness and understanding of its risk factors for early detection and effective treatment. Its rarity underscores the importance of education and awareness, as early diagnosis significantly improves treatment outcomes. Understanding the causes and risk factors is key to prevention and timely medical intervention.

Squamous carcinoma type of penile cancer.
Squamous carcinoma type of penile cancer under the microscope. Source.

What is Penile Cancer?

Penile cancer is a rare form of cancer that occurs on the skin of the penis or within the penis. It most commonly affects the skin cells and can develop anywhere on the penis, but it most often affects the glans or foreskin. This type of cancer is categorized based on the type of cells it originates from, with the most common being squamous cell carcinoma. Early detection is crucial as penile cancer can be effectively treated, especially when caught in its early stages.

How Common is Penile Cancer?

Penile cancer is relatively rare, especially in developed countries. It accounts for less than 1% of cancers in men in the United States and Europe. However, its incidence is higher in parts of Asia, Africa, and South America. The rarity of this cancer in developed countries is largely attributed to better hygiene and widespread circumcision, which are factors known to reduce the risk of penile cancer.

What Causes Penile Cancer?

The exact cause of penile cancer is not entirely understood, but it begins with changes (mutations) in the DNA of cells in the penis, which lead to abnormal growth and the formation of a tumor. These mutations cause cells to grow and divide uncontrollably, and they can eventually spread to other parts of the body. While the precise reasons for these genetic mutations are unknown, several risk factors have been identified.

What are the Risk Factors for Penile Cancer?

Several factors can increase a man's risk of developing penile cancer. One of the most significant is infection with certain types of the human papillomavirus (HPV), particularly HPV 16 and 18, which have been closely linked to this cancer. Smoking is another major risk factor, significantly elevating the chance of developing penile cancer. 

Conditions like phimosis, where the foreskin cannot be retracted from the head of the penis, contribute to the risk, as do poor genital hygiene practices. Age also plays a role, with penile cancer more commonly occurring in men over 50. Men who are uncircumcised face a higher risk, partly due to increased susceptibility to HPV infection and potential hygiene challenges. 

Additionally, men who have undergone UV light treatment for conditions like psoriasis, using psoralens, are at an elevated risk. Moreover, men with AIDS have a higher risk of penile cancer compared to those without the disease. These risk factors highlight the importance of awareness and preventive measures in reducing the likelihood of developing penile cancer.

Can I Prevent Penile Cancer?

While there is no sure way to prevent penile cancer, certain measures can significantly lower your risk. Practicing good genital hygiene is crucial. Regularly cleaning the penis can help prevent the buildup of smegma (the white substance that collects under the foreskin), which is linked to penile cancer. For uncircumcised men, this includes cleaning under the foreskin. Vaccination against HPV can also reduce the risk of penile cancer associated with HPV infection. 

Quitting smoking is another effective measure, as smoking increases the risk of penile and other cancers. Men should also consider using condoms to reduce the risk of HPV infection. Regular self-examinations of the penis can help in early detection of any unusual signs.

What are the Signs and Symptoms of Penile Cancer?

The symptoms of penile cancer can vary, but there are several common signs to watch out for. These include a growth or sore on the penis, often on the glans or foreskin. Changes in the color of the penile skin, a rash, and a discharge with a foul odor are other symptoms. More advanced penile cancer can manifest as bleeding from the penis or a lump on the penis. It is important to consult a doctor if you notice any persistent changes or symptoms in your genital area, as early detection significantly improves the chances of successful treatment.

How is Penile Cancer Diagnosed?

If penile cancer is suspected, the diagnostic process typically starts with a thorough physical examination of the penis. A biopsy is the primary method for diagnosing penile cancer, where a small piece of tissue is removed from any suspicious areas and examined under a microscope for cancer cells. Imaging tests such as ultrasound, MRI, or CT scans may be used to determine if the cancer has spread to other parts of the body. These diagnostic tools help in determining the stage of the cancer, which is crucial for planning the treatment.

How is Penile Cancer Treated?

The treatment for penile cancer depends on the cancer's stage and the patient's overall health. For early-stage penile cancer, treatments aim to remove the cancer while preserving as much of the penis as possible. Options include laser surgery, cryosurgery (freezing cancer cells), and circumcision. In more advanced cases, partial or total penectomy (removal of part or all of the penis) may be necessary. 

Radiation therapy and chemotherapy are other treatment options, used either alone or in combination with surgery. Radiation therapy can be external or internal and is often used to treat both the primary tumor and lymph nodes. Chemotherapy might be recommended if the cancer has spread to other parts of the body.

What are the Side Effects of Penile Cancer Treatment?

Treatment for penile cancer, while necessary, can result in various side effects, depending on the type and extent of treatment. Surgical treatments, especially partial or total penectomy, can have profound physical and psychological impacts, including changes in body image and sexual function. Procedures aimed at preserving the penis may still lead to scarring or changes in sensation. Radiation therapy can cause skin irritation, fatigue, and may affect urinary and sexual function. 

Chemotherapy can lead to side effects such as nausea, hair loss, fatigue, and an increased risk of infections due to lowered immunity. It is important for patients to discuss potential side effects with their healthcare team to prepare and manage them effectively.

Can Penile Cancer Come Back?

Yes, penile cancer can recur. The likelihood of recurrence depends on the stage and type of the original cancer. Close follow-up care after treatment is crucial for early detection of recurrence. This typically involves regular medical check-ups, imaging tests, and sometimes blood tests. If cancer does recur, the treatment may involve similar strategies as the initial treatment or may require a different approach, depending on the specifics of the recurrence and the extent of the cancer.

What is the Prognosis and Survival for Penile Cancer?

The prognosis for penile cancer largely depends on its stage at diagnosis and the type of cancer cells involved. Early-stage penile cancer, which has not spread beyond the skin of the penis, generally has a favorable prognosis with high survival rates. The prognosis becomes less optimistic if the cancer has spread to lymph nodes or distant parts of the body. However, even in more advanced stages, treatment advancements have improved outcomes. The overall 5-year survival rate for penile cancer varies but tends to be higher for those diagnosed at an early stage.

Living with Penile Cancer

Living with and after penile cancer involves physical, emotional, and psychological challenges. Coping with the side effects of treatment, concerns about body image, and changes in sexual health are common experiences for many men. Emotional support from healthcare professionals, counseling services, and support groups can be beneficial. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help manage stress and improve overall well-being. Many men find that engaging in hobbies and social activities can provide a sense of normalcy and control.

Conclusion

Penile cancer, a challenging and sensitive diagnosis, requires a comprehensive approach that encompasses effective medical treatment, management of side effects, psychological support, and lifestyle adjustments. Understanding the potential for treatment side effects, being vigilant about recurrence, knowing the prognosis, and learning how to live with the condition are all critical steps in managing this type of cancer. With advances in medical science and a focus on holistic care, individuals diagnosed with penile cancer can navigate their journey with resilience and hope.

Previous Post          Next Post

Further Reading

  1. Arya M, Kalsi J, Kelly J, Muneer A. Malignant and premalignant lesions of the penis. BMJ. 2013;346:f11491.
  2. Sakalis VI, et al. What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes. Eur Urol Open Sci. 2022;40:582.
  3. Xu J, et al. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis. BMC Cancer. 2019;19:6253.
  4. Stecca CE, et al. Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature. Oncology and Therapy. 2021;9:21–394.
  5. Hansen BT, et al. Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015. Int J Cancer. 2018;142:15865.

Disclaimer: This blog post is intended solely for informational purposes. It is not meant to serve as medical advice. For professional medical guidance, please consult your doctor.

Comments

Popular posts from this blog

What Is Kidney Cancer?

Kidney cancer is a type of cancer that starts in the kidneys, the two bean-shaped organs located on either side of the spine, just below the rib cage. The kidneys play a crucial role in filtering blood, removing waste products and excess fluids, and producing urine. Understanding kidney cancer is vital for early detection and effective treatment. This comprehensive overview covers the basics of kidney cancer, including its types, causes, symptoms, and treatment options. What is Kidney Cancer? Kidney cancer occurs when cells in the kidney grow uncontrollably, forming a tumor. In most cases, kidney cancer originates in the lining of the tiny tubes inside the kidneys (renal tubules). The cancer can spread (metastasize) to other parts of the body if not detected early. There are several types of kidney cancer, with the most common being renal cell carcinoma (RCC). Other less common types include urothelial carcinoma and Wilms tumor, which typically affects children. Causes and Risk Factors

Prostate Cancer: An Overview

Prostate cancer is a concern for men, particularly those over 50 or with a family history of the disease. Understanding prostate cancer is crucial for early detection and effective management. While the prospect of prostate cancer can be daunting, advancements in medical science have made it a highly manageable condition, especially when diagnosed early. In this article, I provide an overview of prostate cancer. Prostate cancer: Location of the prostate gland . Source . What is Prostate Cancer? Prostate cancer is a type of cancer that occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. This cancer is one of the most common types affecting men and tends to grow slowly, often confined to the prostate gland initially, where it may not cause significant harm. However, while some types of prostate cancer grow slowly and may need minimal or no treatment, others are aggressive and can spread quickly and become metasta

How is Kidney Cancer Diagnosed?

Understanding how kidney cancer is diagnosed is crucial for anyone seeking information about this disease, which starts in the kidneys—the organs responsible for filtering waste from the blood and creating urine. Early detection can significantly impact treatment outcomes, making awareness of the diagnostic process essential. This guide aims to break down the steps and methods used by healthcare professionals to diagnose kidney cancer, ensuring you are well-informed about this critical phase of cancer care. Recognizing the Symptoms Often, kidney cancer does not cause noticeable symptoms in its early stages. However, as the cancer grows, symptoms such as blood in the urine (hematuria), lower back pain on one side (not caused by injury), a mass or lump on the side or lower back, fatigue, unexplained weight loss, or fever may prompt a visit to the doctor. Recognizing these signs and seeking medical advice is the first step in the diagnostic process. Initial Consultation and Physical Exam

Benign Prostatic Hyperplasia or BPH

Benign prostatic hyperplasia, commonly known as BPH, is a common condition affecting the prostate gland of men as they age. Characterized by the enlargement of the prostate gland , BPH can significantly impact urinary function and quality of life. This enlargement is non-cancerous but can lead to uncomfortable urinary symptoms. Benign prostatic hyperplasia, commonly known as BPH, is the enlargement of the prostate gland affecting men as they age. Source . How common is benign prostatic hyperplasia? BPH is a very common condition, especially as men age. It is estimated that about half of men over the age of 50 have some degree of benign prostatic hyperplasia, with the number increasing to about 90% of men over 80. Despite its prevalence, not all men with an enlarged prostate experience significant symptom. What causes benign prostatic hyperplasia? The exact cause of benign prostatic hyperplasia is not fully understood, but it is believed to be linked to age-related hormonal changes. As

Pembrolizumab for Renal Cell Carcinoma

Pembrolizumab is a checkpoint inhibitor that belongs to a class of drugs called monoclonal antibodies. Pembrolizumab binds to a protein called programmed cell death-1 (PD-1) on the surface of immune cells called T cells, and prevents it from interacting with another protein called programmed cell death-ligand 1 (PD-L1) on the surface of cancer cells. This interaction normally inhibits the activation and function of T cells, allowing cancer cells to escape immune surveillance and attack. By blocking this interaction, pembrolizumab enhances the ability of T cells to recognize and kill cancer cells. Pembrolizumab, used in the treatment of renal cell carcinoma, is a checkpoint inhibitor and belongs to the class of drugs known as monoclonal antibodies. Source . Pembrolizumab and Axitinib for Renal Cell Carcinoma Pembrolizumab has been approved by the FDA for the treatment of renal cell carcinoma in different settings. In 2019, pembrolizumab was approved in combination with axitinib for the

Metastatic Prostate Cancer

Metastatic prostate cancer means that the cancer has spread beyond the prostate gland to other parts of the body. The likelihood of developing metastatic prostate cancer depends on various factors, including the stage and grade of the cancer at initial diagnosis, age, genetic predispositions, and overall health. Generally, prostate cancers identified early and at a lower grade have a lower risk of becoming metastatic. However, aggressive, or high-grade tumors are more likely to spread beyond the prostate. Bone metastasis of prostate cancer in F-18-Choline PET-CT Scan. Source .  How does metastatic prostate cancer spread? Prostate cancer can metastasize to other internal organs in several ways. One method of metastasis is through the blood vessels, where the cancer cells enter the bloodstream and travel to distant organs. Another pathway is through the lymphatic system, wherein the cancer cells can infiltrate the lymph nodes near the prostate and subsequently spread to other lymph node

Urine Cytology to Diagnose Bladder Cancer

Urine cytology is a crucial diagnostic test used in the detection of bladder cancer. This test involves examining urine samples under a microscope to identify abnormal cells that could indicate the presence of cancer. This article provides an in-depth look at how urine cytology is used to diagnose bladder cancer, its effectiveness, and its role in the broader context of bladder cancer detection and monitoring. Understanding Urine Cytology Urine cytology is a non-invasive diagnostic procedure that helps detect bladder cancer , especially in its early stages. During this test, a urine sample collected from the patient is sent to a laboratory where a cytologist or a pathologist examines the sample under a microscope. The goal is to look for cancerous or pre-cancerous cells shed into the urine from the lining of the bladder. This test is particularly valuable because it can detect cells from tumors that might be missed by other diagnostic methods. How Urine Cytology Is Performed The proces

Prostate Specific Antigen (PSA)

Prostate specific antigen (PSA) is a protein produced by both normal and cancerous cells of the prostate gland. The PSA test measures the level of PSA in the blood and can help detect prostate cancer in men who have no symptoms. However, the PSA test is not perfect and has some limitations and controversies. In this blog post, we will discuss some of the important aspects of PSA testing, such as age-specific PSA levels, free and bound PSA, diagnostic value of PSA, and controversies surrounding PSA screening. Human prostate specific antigen with bound substrate from complex with antibody. Source . Age-specific PSA levels It is normal for all men to have some PSA in their blood, but the amount tends to increase with age. Therefore, some experts have suggested using age-specific PSA ranges to interpret the results of the PSA test. For example, one study proposed the following age-specific PSA ranges for men with no prostate cancer symptoms:  40 to 49 years: 0 to 2.5 ng/mL  50 to 59 years:

Orgovyx for Advanced Prostate Cancer

Orgovyx is an innovative oral medication for advanced prostate cancer treatment. This blog post aims to provide an overview of Orgovyx, its mechanism, benefits, and considerations for those navigating prostate cancer therapy. Orgovyx (Relugolix) is a treatment option for advanced prostate cancer, functioning as part of the androgen deprivation therapy strategy. Source . The Role of Testosterone in Prostate Cancer Testosterone, the primary male sex hormone, plays a pivotal role in the growth and spread of prostate cancer cells. Androgen deprivation therapy (ADT) is a cornerstone in treating advanced prostate cancer, aimed at reducing testosterone levels in the body. Traditional ADT methods include surgery (orchiectomy), testosterone-blocking injections, and pills. Orgovyx is another approach in this context. Orgovyx and ADT Orgovyx belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) receptor antagonists. It operates by blocking the GnRH receptor, thus inhibiting

Pluvicto for Advanced Prostate Cancer

Pluvicto, also called Lutetium Lu 177 vipivotide tetraxetan, is a treatment option for men battling advanced prostate cancer. This article delves into the mechanics, benefits, and considerations of Pluvicto. Pluvicto, also called Lutetium Lu 177 vipivotide tetraxetan, is a treatment option for men battling advanced prostate cancer. Source . What is Pluvicto and How Does It Work? Pluvicto is a type of targeted radiation therapy, specifically formulated to attack prostate cancer cells expressing PSMA (prostate-specific membrane antigen). The drug consists of a PSMA-binding molecule linked to lutetium-177, a radioactive atom. When administered, Pluvicto targets PSMA-positive cancer cells, delivering potent radiation directly to the tumor sites while minimizing impact on healthy cells. This selective approach damages the DNA of cancer cells, leading to their destruction. The Dual Role of Pluvicto: Theranostic Applications One of the unique aspects of Pluvicto is its theranostic capability,